JNJ Johnson & Johnson
- Stocks
- Healthcare
- NYSE: JNJ
Price (delayed)
$170.74
Market cap
$411.2B
P/E Ratio
18.14
Dividend/share
$5.02
EPS
$9.41
Enterprise value
$443.38B
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones
Highlights
JNJ's price to earnings (P/E) is 18% lower than its 5-year quarterly average of 22.0 and 16% lower than its last 4 quarters average of 21.5
JNJ's equity is up by 10% year-on-year
Johnson & Johnson's net income has decreased by 40% YoY but it has increased by 3.9% QoQ
The EPS has contracted by 38% YoY but it has grown by 3.9% from the previous quarter
The quick ratio has decreased by 29% QoQ and by 12% YoY
Key stats
What are the main financial stats of JNJ
Market
Valuations
Earnings
Shares outstanding
2.41B
Market cap
$411.2B
Enterprise value
$443.38B
Price to earnings (P/E)
18.14
Price to book (P/B)
5.24
Price to sales (P/S)
4.53
EV/EBIT
15.73
EV/EBITDA
12.44
EV/Sales
4.89
Revenue
$90.63B
Gross profit
$61.55B
Operating income
$21.45B
Net income
$22.66B
EBIT
$28.19B
EBITDA
$35.65B
Free cash flow
$18.55B
Per share
Balance sheet
Liquidity
EPS
$9.41
EPS diluted
$9.35
Free cash flow per share
$7.71
Book value per share
$32.61
Revenue per share
$37.66
TBVPS
$39.66
Total assets
$193.39B
Total liabilities
$114.92B
Debt
$50.76B
Equity
$78.47B
Working capital
$318M
Debt to equity
0.65
Current ratio
1.01
Quick ratio
0.68
Net debt/EBITDA
0.9
Margins
Efficiency
Dividend
EBITDA margin
39.3%
Gross margin
67.9%
Net margin
25%
Operating margin
23.7%
Return on assets
12.2%
Return on equity
30.4%
Return on invested capital
43.2%
Return on capital employed
20.2%
Return on sales
31.1%
Dividend yield
2.94%
DPS
$5.02
Payout ratio
53.3%
JNJ stock price
How has the Johnson & Johnson stock price performed over time
Intraday
-0.18%
1 week
1.56%
1 month
9.44%
1 year
5.89%
YTD
18.06%
QTD
11.78%
Financial performance
How have Johnson & Johnson's revenue and profit performed over time
Revenue
$90.63B
Gross profit
$61.55B
Operating income
$21.45B
Net income
$22.66B
Gross margin
67.9%
Net margin
25%
Johnson & Johnson's net margin has decreased by 43% YoY but it has increased by 2.5% from the previous quarter
Johnson & Johnson's net income has decreased by 40% YoY but it has increased by 3.9% QoQ
Johnson & Johnson's operating margin has decreased by 6% YoY
JNJ's revenue is up by 4.7% year-on-year
Price vs fundamentals
How does JNJ's price correlate with its fundamentals
Growth
What is Johnson & Johnson's growth rate over time
Valuation
What is Johnson & Johnson stock price valuation
P/E
18.14
P/B
5.24
P/S
4.53
EV/EBIT
15.73
EV/EBITDA
12.44
EV/Sales
4.89
The EPS has contracted by 38% YoY but it has grown by 3.9% from the previous quarter
JNJ's price to earnings (P/E) is 18% lower than its 5-year quarterly average of 22.0 and 16% lower than its last 4 quarters average of 21.5
JNJ's equity is up by 10% year-on-year
JNJ's price to book (P/B) is 8% less than its 5-year quarterly average of 5.7 but 4.8% more than its last 4 quarters average of 5.0
The price to sales (P/S) is 9% less than the 5-year quarterly average of 5.0 but 8% more than the last 4 quarters average of 4.2
JNJ's revenue is up by 4.7% year-on-year
Efficiency
How efficient is Johnson & Johnson business performance
The return on assets has declined by 45% year-on-year but it has increased by 2.5% since the previous quarter
The company's return on equity fell by 44% YoY
Johnson & Johnson's return on invested capital has decreased by 38% YoY and by 2.5% QoQ
The ROS has contracted by 36% YoY
Dividends
What is JNJ's dividend history
DPS
$5.02
Dividend yield
2.94%
Payout ratio
53.3%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Johnson & Johnson financials performed over time
JNJ's total assets is 68% greater than its total liabilities
The quick ratio has decreased by 29% QoQ and by 12% YoY
JNJ's current ratio is down by 20% since the previous quarter and by 6% year-on-year
Johnson & Johnson's debt is 35% less than its equity
Johnson & Johnson's debt has increased by 22% YoY but it has decreased by 2.9% from the previous quarter
The company's debt to equity rose by 12% YoY but it fell by 3% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.